Published on GHDx (https://ghdx.healthdata.org)

High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint

General Info

Provider 
Elsevier
Tabulations only
Geography 
Kenya (KEN)
Nairobi City
Coverage type 
Subnational
Time period covered 
November, 2020 - November, 2020
Data type
Scientific literature
Keywords 
Blood tests, COVID-19, Disease outbreaks, Infectious diseases, Medical tests

Citation

Authors 
Ngere IA, Dawa J, Hunsperger E, Otieno N, Masika M, Amoth P, Makayotto L, Nasimiyu C, Gunn BM, Nyawanda B, Oluga O, Ngunu C, Mirieri H, Gachohi J, Marwanga D, Munywoki P, Odhiambo D, Alando MD, Breiman R, Anzala O, Njenga MK, Bulterys M, Herman-Roloff A, Osoro E
Journal 
Prepr Lancet
Publication year 
2021
Suggested citation 
Ngere IA, Dawa J, Hunsperger E, Otieno N, Masika M, Amoth P, Makayotto L, Nasimiyu C, Gunn BM, Nyawanda B, Oluga O, Ngunu C, Mirieri H, Gachohi J, Marwanga D, Munywoki P, Odhiambo D, Alando MD, Breiman R, Anzala O, Njenga MK, Bulterys M, Herman-Roloff A, Osoro E. High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint. Prepr Lancet. 2021.
Source URL:https://ghdx.healthdata.org/record/high-seroprevalence-sars-cov-2-eight-months-after-introduction-nairobi-kenya-preprint